Alaunos Therapeutics share price logo

Alaunos Therapeutics

NASDAQ: TCRT

$2.63

+0.45

(+20.64%)

as on

Alaunos Therapeutics Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.31
    $2.99
    downward going graph

    12.17%

    Downside

    13.69%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.72
    $4.50
    downward going graph

    72.66%

    Downside

    71.10%

    Upside

    downward going graph

Alaunos Therapeutics share price movements today

Previous Close
$2.18
Open
$2.81
Volume
19.7M
Market Cap
$6.4M
Day's Low - High
$2.31 - $2.99
52 Week Low - High
$0.72 - $4.50

Alaunos Therapeutics Historical Returns

1 Month Return
+ 64.37 %
3 Month Return
+ 28.29 %
1 Year Return
-14.33 %
3 Year Return
-84.69 %
5 Year Return
0 %

Alaunos Therapeutics Stock Fundamentals & Key Indicators

Check Alaunos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.4M

EPS (TTM)

-1.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.12

Industry PE ratio

-2.36

PEG Ratio

-0.05

EBITDA

-4.0M

Revenue (TTM)

3.0K

Profit Margin

-28133.33%

Return On Equity TTM

-232.60%

Alaunos Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alaunos Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Alaunos Therapeutics image
Alaunos Therapeutics
Hold$6.4MNA-1.12-28133.33%0.00%
Moderna image
Moderna
Neutral$94.4B-32.76%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$128.9B174.93%29.3786.04%0.00%
Regeneron image
Regeneron
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Alaunos Therapeutics Stock including INR - Dollar returns

The Alaunos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Alaunos Therapeutics investment value today

Current value as on today

₹92,453

Returns

-₹7,547

(-7.55%)

Returns from Alaunos Therapeutics Stock

-₹14,332 (-14.33%)

Dollar Impact

₹6,786 (+6.79%)

Analyst Recommendation on Alaunos Therapeutics Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Alaunos Therapeutics. Average target price of $1.75

Alaunos Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Alaunos Therapeutics.

What analysts predicted

-50.29%DOWNSIDE

Target Price

$1.75

Current Price

$2.63

Analyzed by

6 Analysts

Target

$1.75

Alaunos Therapeutics target price $1.75, a slight downside of -50.29% compared to current price of $2.63. According to 6 analysts rating.

Indian Investors' Interest in Alaunos Therapeutics Stock

Search interest for Alaunos Therapeutics Stock has increased by 12095% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12095% versus previous 30 day period

Alaunos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
-
0
0
-
-
0
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-1
0
-1
-1
-1
0
-1
0
EBITDA
-1
-1
-1
0
-1
-1
-1
0
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
-
0
-
0
-
0
0
0
Income Before Tax
-1
-1
-1
0
-1
-1
-1
0
-1
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-1
-1
0
-1
-1
-1
0
-1
0
Net Profit Margin
-100.00%
-4400.00%
0.00%
100.00%
-17250.00%
0.00%
0.00%
-11933.33%
0.00%
0.00%

Alaunos Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
0
-
-
0
2
0
0
0
Gross Profit
6
0
0
-1
-46
-19
-4
0
-1
Operating Income
-53
-53
-57
-80
-77
-35
-34
-4
-4
EBITDA
-53
-53
-117
-78
-74
-31
-30
-4
-4
Interest Expense
0
-
-
-
1
3
1
-
-
Depreciation
0
0
0
1
2
2
2
0
0
Income Before Tax
-54
-53
-117
-79
-78
-37
-35
-4
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-54
-53
-117
-79
-78
-37
-35
-4
-4
Net Profit Margin
100.00%
100.00%
0.00%
0.00%
100.00%
100.00%
-95960.00%
100.00%
-27160.00%

Alaunos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-1
-1
0
-1
-1
-1
0
-1
0
Operating Cash Flow
-1
-1
0
0
0
0
0
0
-1
0
Investing Cash Flow
-
-
-
-
-
-
0
0
-
-
Financing Cash Flow
-
-
-
-
-
3
-
-
-
0
Change in Cash
-1
-1
0
0
0
2
0
0
-1
0

Alaunos Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-54
-53
-117
-79
-78
-37
-35
-4
-4
Operating Cash Flow
-54
-49
-40
-57
-61
-29
-30
-4
-2
Investing Cash Flow
0
0
0
-9
-3
0
1
-
0
Financing Cash Flow
45
40
59
102
25
6
-18
-
3
Change in Cash
-10
-9
18
35
-39
-23
-46
-4
0

Global Institutional Holdings in Alaunos Therapeutics

Check out the Institutions with significant holdings in Alaunos Therapeutics.

Funds
Holdings
Victory Portfolios III
0.83%
Fidelity Concord Street Trust
0.62%
VANGUARD INDEX FUNDS
0.48%
Vanguard
0.48%

Alaunos Therapeutics News & Key Events

  • img

    Today's Timeline - 13 October

    Tue, 08:15 PM

    -

    Alaunos completes acquisition of Velaris Therapeutics, enhancing its pipeline for pulmonary diseases and raising $350M in private placement.

Insights on Alaunos Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, TCRT stock has moved up by 234.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.0K → 3.0K (in $), with an average increase of 33.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.00M → -952.0K (in $), with an average increase of 5.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 752.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 237.2%

About Alaunos Therapeutics

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., a research and development partnership with The University of Texas MD Anderson Cancer Center, and both a patent licensing and R&D agreement with the National Cancer Institute. Previously known as ZIOPHARM Oncology, Inc., the company adopted its current name, Alaunos Therapeutics, Inc., in January 2022. Its headquarters are located in Houston, Texas.
OrganisationAlaunos Therapeutics
Headquarters501 E. Las Olas Blvd., Fort Lauderdale, FL, 33301, US
IndustryBiotechnology
CEOHolger Weis

Key Management of Alaunos Therapeutics

Name

Title

Mr. Holger Weis CPA

Chairman of the Board & CEO

Mr. Ferdinand Groenewald

Vice President of Finance & Corporate Secretary

FAQs

What is Alaunos Therapeutics share price today?

Alaunos Therapeutics share price today is $2.63 as on at the close of the market. Alaunos Therapeutics share today touched a day high of $2.99 and a low of $2.31.

What is the 52 week high and 52 week low for Alaunos Therapeutics share?

Alaunos Therapeutics share touched a 52 week high of $4.50 on and a 52 week low of $0.72 on . Alaunos Therapeutics stock price today i.e. is closed at $2.63,which is 41.56% down from its 52 week high and 265.79% up from its 52 week low.

What is Alaunos Therapeutics's market capitalisation today?

Alaunos Therapeutics market capitalisation is $0.00T as on .

How to invest in Alaunos Therapeutics Stock (TCRT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alaunos Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Alaunos Therapeutics Stock (TCRT) from India?

Indian investors can start investing in Alaunos Therapeutics (TCRT) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Alaunos Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Alaunos Therapeutics share’s latest price of $2.63 as on October 17, 2026 at 8:46 am IST, you will get 3.8023 shares of Alaunos Therapeutics. Learn more about fractional shares .